Ellard SL - Search Results

1

Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.

Koelwyn GJ, Lewis NC, Ellard SL, Jones LW, Gelinas JC, Rolf JD, Melzer B, Thomas SM, Douglas PS, Khouri MG, Eves ND. Koelwyn GJ, et al. Among authors: ellard sl. Oncologist. 2016 Feb;21(2):141-9. doi: 10.1634/theoncologist.2015-0352. Epub 2016 Jan 13. Oncologist. 2016. PMID: 26764251 Free PMC article.

2

Utilizing RE-AIM to examine the translational potential of Project MOVE, a novel intervention for increasing physical activity levels in breast cancer survivors.

Pullen T, Bottorff JL, Sabiston CM, Campbell KL, Eves ND, Ellard SL, Gotay C, Fitzpatrick K, Sharp P, Caperchione CM. Pullen T, et al. Among authors: ellard sl. Transl Behav Med. 2019 Jul 16;9(4):646-655. doi: 10.1093/tbm/iby081. Transl Behav Med. 2019. PMID: 30060250

3

Innovative approach for increasing physical activity among breast cancer survivors: protocol for Project MOVE, a quasi-experimental study.

Caperchione CM, Sabiston CM, Clark MI, Bottorff JL, Toxopeus R, Campbell KL, Eves ND, Ellard SL, Gotay C. Caperchione CM, et al. Among authors: ellard sl. BMJ Open. 2016 Aug 16;6(8):e012533. doi: 10.1136/bmjopen-2016-012533. BMJ Open. 2016. PMID: 27531738 Free PMC article.

4

A preliminary trial examining a 'real world' approach for increasing physical activity among breast cancer survivors: findings from project MOVE.

Caperchione CM, Sabiston CM, Stolp S, Bottorff JL, Campbell KL, Eves ND, Ellard SL, Gotay C, Sharp P, Pullen T, Fitzpatrick KM. Caperchione CM, et al. Among authors: ellard sl. BMC Cancer. 2019 Mar 27;19(1):272. doi: 10.1186/s12885-019-5470-2. BMC Cancer. 2019. PMID: 30917793 Free PMC article.

5

Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole.

McArthur HL, Gelmon KA, Olivotto IA, Speers CH, Ellard SL, O'Reilly SE, Kennecke HF. McArthur HL, et al. Among authors: ellard sl. J Clin Oncol. 2009 Mar 20;27(9):1388-93. doi: 10.1200/JCO.2008.18.4127. Epub 2009 Feb 23. J Clin Oncol. 2009. PMID: 19237634

6

A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer.

Azad AA, Beardsley EK, Hotte SJ, Ellard SL, Klotz L, Chin J, Kollmannsberger C, Mukherjee SD, Chi KN. Azad AA, et al. Among authors: ellard sl. Invest New Drugs. 2014 Aug;32(4):746-52. doi: 10.1007/s10637-014-0091-8. Epub 2014 Mar 28. Invest New Drugs. 2014. PMID: 24671507 Clinical Trial.

7

Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.

Wilson S, Speers C, Tyldesley S, Chia S, Kennecke H, Ellard S, Lohrisch C. Wilson S, et al. Clin Breast Cancer. 2016 Aug;16(4):284-90. doi: 10.1016/j.clbc.2015.11.002. Epub 2015 Nov 17. Clin Breast Cancer. 2016. PMID: 26705158

8

Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.

Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA. Kennecke H, et al. Cancer. 2008 Apr 1;112(7):1437-44. doi: 10.1002/cncr.23320. Cancer. 2008. PMID: 18286526 Free article.

9

Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.

Ellard SL, Clemons M, Gelmon KA, Norris B, Kennecke H, Chia S, Pritchard K, Eisen A, Vandenberg T, Taylor M, Sauerbrei E, Mishaeli M, Huntsman D, Walsh W, Olivo M, McIntosh L, Seymour L. Ellard SL, et al. J Clin Oncol. 2009 Sep 20;27(27):4536-41. doi: 10.1200/JCO.2008.21.3033. Epub 2009 Aug 17. J Clin Oncol. 2009. PMID: 19687332 Clinical Trial.

10

A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer.

Rathkopf DE, Picus J, Hussain A, Ellard S, Chi KN, Nydam T, Allen-Freda E, Mishra KK, Porro MG, Scher HI, Wilding G. Rathkopf DE, et al. Cancer Chemother Pharmacol. 2013 Sep;72(3):537-44. doi: 10.1007/s00280-013-2224-8. Epub 2013 Jul 3. Cancer Chemother Pharmacol. 2013. PMID: 23820963 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page